- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/32 - 1,4-OxazinesHydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
Patent holdings for IPC class C07D 265/32
Total number of patents in this class: 165
10-year publication summary
|
8
|
5
|
5
|
11
|
2
|
11
|
10
|
10
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 137 |
9 |
| California Institute of Technology | 4023 |
7 |
| Sandoz AG | 1409 |
5 |
| Amgen Inc. | 4385 |
5 |
| Massachusetts Institute of Technology | 10210 |
4 |
| Gen1e Lifesciences Inc. | 30 |
4 |
| Schering Corporation | 366 |
3 |
| TriStar Global Energy Solutions, Inc. | 29 |
3 |
| Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 31 |
3 |
| Cr3 Zymeflow, Inc. | 29 |
3 |
| Zymeflow, Inc. | 45 |
3 |
| Glaxo Group Limited | 4395 |
2 |
| Glaxosmithkline LLC | 529 |
2 |
| 3m Innovative Properties Company | 17491 |
2 |
| BASF SE | 21171 |
2 |
| The Regents of the University of California | 20611 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Agency for Science, Technology and Research | 3698 |
2 |
| Apotex Pharmachem Inc. | 22 |
2 |
| Chengdu Di'ao Pharmaceutical Group Co., Ltd. | 25 |
2 |
| Other owners | 98 |